跳至主要内容
临床试验/ISRCTN14196090
ISRCTN14196090暂停未知

Primary pneumothorax fluorescein-enhanced thoracoscopy

niversity of Oxford0 个研究点目标入组 28 人开始时间: 2020年3月12日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Other

入排标准

性别
All

入选标准

  • 1. Patient undergoing Video-assisted Thoracoscopic Surgery (VATS) for pneumothorax recurrence prevention, or ongoing air leak (pneumothorax group) OR Thoracic surgery for another indication, for example, early-stage lung cancer or metastasis resection (control group).
  • 2. Male or female aged between 16 and 55 years (inclusive)

排除标准

  • 1. Inability to consent or comply with the trial requirements
  • 2. Patients in the control group should not have demonstrable emphysema (on CT scanning) and should not have experienced a spontaneous pneumothorax in the past
  • 3. Allergy to fluorescein
  • 4. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the trial, or the participant’s ability to participate in the study

研究者

相似试验